No Data
Disc Medicine Advances Bitopertin Trial for EPP
Disc Medicine Announces Feedback From Type C Meeting With FDA
Express News | Disc Medicine : Plans to Initiate Apollo Trial by Mid-2025 and Will Include Sites in US, Canada, Europe, and Australia
Express News | Disc Medicine Inc - Planning to Submit Nda Under Accelerated Approval Pathway in H2 2025
Disc Medicine Announces Successful Type C Meeting With FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission
Express News | Reported Monday, Disc Medicine Announces Conference Call To Review FDA Feedback On Bitopertin For EPP
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
far008 : $Vast Renewables (VSTE.US)$ has no short shares. we should see an uptick
103822628 : Sorry , unusual volume ticks means wat?
Stock_Drift OP 103822628 : Look at the volume. It’s unusual